“Our fourth quarter results demonstrated sustained growth and execution in our first full year post-merger,” commented Keith Pfeil, COO-CFO. “As we begin 2025, we seek to build upon the successes of the past year, further solidifying our foundation which will drive accelerated growth across our portfolio, as we move ahead in a manner that advances patient care while creating value for our shareholders.”
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- Globus Medical price target raised to $90 from $85 at Truist
- Globus Medical price target raised to $115 from $100 at Roth MKM
- Globus Medical price target raised to $91 from $87 at BTIG
- Globus Medical price target raised to $92 from $85 at Canaccord
- Globus Medical assumed at Overweight from Equal Weight at Morgan Stanley